Tonira Pharma Ltd. [Merged]
BSE: 530155
₹19.75
₹0.25
(1.28%)
As on 29-May-2012IST
Market cap
₹16 Cr
Revenue (TTM)
₹34 Cr
P/E Ratio
--
P/B Ratio
1.6
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-3 Cr
-
ROE
-15.7 %
-
ROCE
2 %
-
Industry P/E
40.16
-
EV/EBITDA
34
-
Debt to Equity
3
-
Book Value
₹--
-
EPS
₹-4.9
-
Face value
10
-
Shares outstanding
7,944,200
10 Years Aggregate
CFO
₹19.98 Cr
EBITDA
₹36.77 Cr
Net Profit
₹2.74 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Tonira Pharma [Merged]
| 26.3 | -0.8 | 9.1 | -10.6 | -1.2 | -1.7 | 22.7 |
|
BSE Sensex*
| -8.9 | 1.4 | 1.5 | -4.5 | 5.9 | 6.6 | 10.8 |
|
BSE Healthcare#
| 18.1 | 3.8 | 8.1 | 16.3 | 22.9 | 14.9 | 12.3 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Tonira Pharma [Merged]
|
19.8 | 15.7 | 33.5 | -3.4 | -7.2 | -35.4 | -- | 1.6 |
| 3,316.0 | 27,186.1 | 1,461.8 | 387.4 | 34.5 | 25.2 | 70.4 | 15.7 | |
| 831.1 | 16,236.1 | 7,784.0 | 688.5 | 10.6 | 14 | 23.4 | 2.8 | |
| 458.7 | 17,459.8 | 2,141.5 | 58.5 | 5.8 | 3.3 | 164.4 | 4.5 | |
| 837.5 | 20,475.5 | 5,632.3 | 662.4 | 17.2 | 14.3 | 30.9 | 4.2 | |
| 1,528.0 | 17,217.6 | 1,543.3 | -48.6 | 3.6 | -0.6 | -- | 2.9 | |
| 217.8 | 28,284.5 | 9,205.3 | -371.8 | 1.7 | -3.8 | -- | 3.5 | |
| 1,843.1 | 29,986.1 | 1,935.8 | 288.2 | 20.6 | 29.8 | 104 | 22.3 | |
| 414.4 | 16,681.6 | 3,600.2 | 221.0 | 9.7 | 5.6 | 75.5 | 3.5 | |
| 1,965.0 | 30,609.5 | 3,564.0 | 414.0 | 15.3 | 8.4 | 74.8 | 6.1 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Tonira Pharma [Merged]
Manufacture of allopathic pharmaceutical preparations
-
Incorporated
1992
-
Chairman
Bhailalbhai B Shah
-
Managing Director
R K P Verma
-
Headquarters
Nandesari, Gujarat
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Tonira Pharma [Merged]
What is the current share price of Tonira Pharma Ltd [Merged] Today?
The share price of Tonira Pharma Ltd [Merged] is ₹19.75 (BSE) as of 29-May-2012 IST. Tonira Pharma Ltd [Merged] has given a return of -1.23% in the last 3 years.
What is the current PB & PE ratio of Tonira Pharma Ltd [Merged]?
Since, TTM earnings of Tonira Pharma Ltd [Merged] is negative, P/E ratio is not available.
The P/B ratio of Tonira Pharma Ltd [Merged] is 1.58 times as on 29-May-2012, a 62 discount to its peers’ median range of 4.16 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2011 |
0.00 |
1.22 |
2010 |
25.15 |
1.80 |
2009 |
0.00 |
0.86 |
2008 |
0.00 |
1.56 |
2007 |
8.26 |
0.69 |
What is the 52 Week High and Low of Tonira Pharma Ltd [Merged]?
The 52-week high and low of Tonira Pharma Ltd [Merged] are Rs -- and Rs -- as of 27-Aug-2026.
What is the market cap of Tonira Pharma Ltd [Merged]?
Tonira Pharma Ltd [Merged] has a market capitalisation of ₹ 16 Cr as on 29-May-2012. As per SEBI classification, it is a company.
Should I invest in Tonira Pharma Ltd [Merged]?
Before investing in Tonira Pharma Ltd [Merged], assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.